学说

Results β-Stigmasterol (1), quercetin (2), myricetin 3'-methyl ether (3), syringetin-3-0-α-L-arabinofuranosid (4), ardicrenin (5) and ardisiacrispin A (6) were isolated and identified.

结果 分离并鉴定出6个化合物：β-豆甾醇(1)、槲皮素(2)、3'-甲基杨梅黄酮(3)、丁香亭－3-O-α-L-阿拉伯呋喃糖苷(4)、ardicrenin(5)和ardisiacrispin A(6)。

After a two-week screening period, 18 patients participated in a four-week as-required regimen of 2 mg apomorphine SL, escalated to 3 mg when appropriate after two weeks. Three patients (16.7%) benefited from this treatment modality ( P .05). The nonresponding group of 15 patients continued with a daily regimen of 2 mg apomorphine SL for two weeks followed by 3 mg daily for two weeks. The 3 mg daily regimen was more effective for ED ( P .02) and for each sexual domain scored with the International Index of Erectile Function questionnaire. Adverse events, as reported by three patients (23%) during the 3 mg regimen, were nausea, dizziness, and headache.

在二星期的筛检过程之后，18位病患参与为期四个星期的2mg，在两星期后适当的增加至3mg的阿朴吗啡 SL疗法，其中三位病患(16.7%)受益于这种治疗方法(P 。05)，15位无反应的病患持续接受每日2 mg的阿朴吗啡 SL两周后，再接著以每日3 mg的两周治疗，对于ED及国际勃起功能指数调查表的每项性功能区计分，每日3 mg的疗法比较有效(P 。02)，在接受3 mg疗法期间三位病患( 23%)的不良事件，为恶心、眩晕、和头痛。